EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Marine and algae Sources: 13

Carrageenan and agar

Also called: carrageenan, E 407, processed Eucheuma seaweed (E 407a), agar, agar-agar, E 406, kanten

Carrageenan and agar are polysaccharides extracted from red seaweeds and used as food additives. Carrageenan serves as an emulsifier, stabilizer or thickener; agar-agar as a stabilizer, thickener, flavoring agent or drying agent. Both are permitted in US and EU foods.

Category
Marine and algae
Forms
Carrageenan: refined hydrocolloid from Chondrus, Eucheuma and Gigartina species; agar: dried colloidal polysaccharide from red algae
Strongest evidence
C Limited
Reviewed
2026-10-28

Class 2 Moderately studied in people. This entry cites 8 RCTs of carrageenan or agar alone taken by mouth: carrageenan in sources 3, 4, 9 and 10 (7 to 20 participants); agar in sources 5 and 11-13 (10 to 160 participants). Source 13's abstract does not state randomization; MEDLINE indexes it as an RCT. [3]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied2 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Carrageenan and agar does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Carrageenan and agar, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Relapse of ulcerative colitis with carrageenanCRCT of 12 people with ulcerative colitis in remission on a no-carrageenan diet: 3 given carrageenan capsules relapsed versus none given placebo, within up to one year. [3]
Inflammation and gut symptoms in ulcerative colitisCCrossover pilot RCT in 7 people with quiescent ulcerative colitis: 7 days of food-grade carrageenan did not change disease activity or inflammatory markers versus placebo. [4]
Weight in obese adults with impaired glucose tolerance or type 2 diabetes (agar)CRCT in 76 patients: adding agar to a conventional diet for 12 weeks gave greater weight loss (−2.8 vs −1.3 kg) and total cholesterol reduction than diet alone. [5]

Main constituents: Carrageenan: sulfated polysaccharide of galactose and anhydrogalactose units, 20% to 40% sulfate (dry weight) [1]; Agar-agar: dried, hydrophilic, colloidal polysaccharide [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Agar 4,500 mg per person per day (about 64 mg/kg body weight) was tolerated for 12 weeks without noticeable side effects. [6]

Upper limits

  • EFSA (2018): group acceptable daily intake of 75 mg/kg body weight per day for carrageenan (E 407) and processed Eucheuma seaweed (E 407a), considered temporary pending better data. [7]
  • EFSA (2016): no numerical ADI needed for agar (E 406). [6]
  • US: agar-agar maximum use levels are 0.8% in baked goods, 2.0% in confections and frostings, 1.2% in soft candy and 0.25% in all other foods. [2]
Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    2 found

    Each names the exact material tested, which may differ from a supplement.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • EFSA: carrageenan is not absorbed intact; no concern for genotoxicity or carcinogenicity; no adverse effects in chronic rat studies up to 7,500 mg/kg body weight per day. Uncertainties remain in chemistry, exposure and toxicology data. [7]
  • Poligeenan (average molecular weight 10–20 kDa) is not authorized as a food additive and is not used in foods. [7]
  • EFSA: agar is unlikely to be absorbed unchanged, is slightly fermented by gut bacteria, and raises no safety concern at reported uses. [6]
Quality

Identity, quality and standardization

  • US labels must name the additive 'carrageenan'; salts of carrageenan are labeled by the dominant salt, e.g., 'sodium carrageenan' or 'potassium carrageenan'. [8]
  • US agar-agar must meet Food Chemicals Codex specifications. [2]
Regulation

Regulatory status

  • US: carrageenan is a permitted food additive (21 CFR 172.620) as an emulsifier, stabilizer or thickener; salts of carrageenan are covered by 21 CFR 172.626. [1]
  • US: agar-agar is listed under 21 CFR 184.1115 (direct food substances affirmed as GRAS) as a drying agent, flavoring agent, stabilizer and thickener. [2]
  • EU: carrageenan (E 407), processed Eucheuma seaweed (E 407a) and agar (E 406) are authorized food additives that EFSA re-evaluated in 2018 and 2016. [7]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Carrageenan: sulfated polysaccharide whose dominant hexose units are galactose and anhydrogalactose (sulfate content 20–40% dry weight) Polysaccharides (sulfated galactan) [P4]
  • Agar-agar: dried, hydrophilic, colloidal polysaccharide extracted from red algae (class Rhodophyceae) Polysaccharides [P5]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming carrageenan or agar was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29); two entries name oligosaccharide ingredients ('Agaro-oligosaccharide', NDI 126, submitted 2001-10-18; 'neoagarooligosaccharides', NDI 1237, submitted 2021-11-24), not agar itself. FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P1]
  • Carrageenan is a food additive permitted under 21 CFR 172.620, defined as the refined hydrocolloid prepared by aqueous extraction from listed red seaweeds of the families Gigartinaceae and Solieriaceae. [P4]
  • 21 CFR 184.1115 lists agar-agar for use in food under stated maximum levels (for example 0.8% in baked goods and baking mixes, 2.0% in confections and frostings, 0.25% in all other food categories, as served). [P5]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • IARC: Carrageenan, native, Group 3 (not classifiable), Volume 31 and Supplement 7 (1987). Carrageenan, degraded (poligeenan), Group 2B (possibly carcinogenic to humans), Volume 31 and Supplement 7 (1987). These are two different materials. [P3]
  • EFSA (2018) states that poligeenan (average molecular weight 10–20 kDa) has not been authorised as a food additive and is not used in any food applications, and found no concern with respect to the carcinogenicity of food-grade carrageenan (E 407). [P6]
  • NTP TR-230 (March 1982): agar isolated from Pterocladia, fed at 25,000 or 50,000 ppm for 103 weeks, was not carcinogenic for F344 rats or B6C3F1 mice of either sex. No IARC classification of agar was found. [P8]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition for an exemption under 111.75(a)(1)(ii). [P2]
  • Sulfate content (carrageenan) — 21 CFR 172.620(b) specifies a sulfate content of 20 to 40 percent on a dry-weight basis for carrageenan. [P4]
  • Food Chemicals Codex specifications (agar) — 21 CFR 184.1115(b) states agar-agar meets the specifications of the Food Chemicals Codex, 3d Ed. (1981). [P5]

Supply and conservation

  • 21 CFR 172.620 names the source seaweeds for carrageenan: Chondrus crispus, Chondrus ocellatus, Eucheuma cottonii, Eucheuma spinosum, Gigartina acicularis, Gigartina pistillata, Gigartina radula and Gigartina stellata. [P4]
  • 21 CFR 184.1115: agar-agar is extracted from one of a number of related species of red algae (class Rhodophyceae). [P5]

Absorption in people

  • EFSA (2018): the ADME database was sufficient to conclude that carrageenan was not absorbed intact. [P6]
  • EFSA (2016): agar is unlikely to be absorbed unchanged and is slightly fermented by intestinal microbiota; an oral intake of 4,500 mg/person (64 mg/kg bw per day) was tolerated in humans for 12 weeks without noticeable side effects. [P7]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  3. IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  4. eCFR. 21 CFR 172.620 Carrageenan (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  5. eCFR. 21 CFR 184.1115 Agar-agar (up to date as of 10/15/2026), 2026-10-15. ecfr.gov
  6. EFSA ANS Panel. Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives. EFSA J 2018;16(4):e05238 (PMID 32625873), 2018-04-26. pubmed.ncbi.nlm.nih.gov
  7. EFSA ANS Panel. Re-evaluation of agar (E 406) as a food additive. EFSA J 2016;14(12):e04645 (PMID 42006017), 2016-12-21. pubmed.ncbi.nlm.nih.gov
  8. National Toxicology Program. TR-230: Carcinogenesis Bioassay of Agar in F344 Rats and B6C3F1 Mice (Feed Study) (March 1982), 1982-03. ntp.niehs.nih.gov
Sources

Sources

  1. eCFR. 21 CFR 172.620 Carrageenan (current as of October 27, 2026), 2026-10-27. ecfr.gov
  2. eCFR. 21 CFR 184.1115 Agar-agar (current as of October 27, 2026), 2026-10-27. ecfr.gov
  3. Bhattacharyya S, et al. A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. Nutr Healthy Aging 2017;4(2):181-192, 2017-03-31. pubmed.ncbi.nlm.nih.gov
  4. Laatikainen R, et al. Randomized controlled pilot study: effect of carrageenan emulsifier on inflammation and gastrointestinal symptoms in quiescent ulcerative colitis. Food Nutr Res 2023;67, 2023-10-30. pubmed.ncbi.nlm.nih.gov
  5. Maeda H, et al. Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes. Diabetes Obes Metab 2005;7(1):40-6, 2005-01. pubmed.ncbi.nlm.nih.gov
  6. EFSA ANS Panel. Re-evaluation of agar (E 406) as a food additive. EFSA J 2016;14(12):e04645, 2016-12-21. pubmed.ncbi.nlm.nih.gov
  7. EFSA ANS Panel. Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives. EFSA J 2018;16(4):e05238, 2018-04-26. pubmed.ncbi.nlm.nih.gov
  8. eCFR. 21 CFR 172.626 Salts of carrageenan (current as of October 27, 2026), 2026-10-27. ecfr.gov
  9. Wagner R, et al. Carrageenan and insulin resistance in humans: a randomised double-blind cross-over trial. BMC Med 2024;22(1):558 (PMID 39593091), 2024-11-26. pubmed.ncbi.nlm.nih.gov
  10. Panlasigui LN, et al. Blood cholesterol and lipid-lowering effects of carrageenan on human volunteers. Asia Pac J Clin Nutr 2003;12(2):209-14 (PMID 12810413), 2003. pubmed.ncbi.nlm.nih.gov
  11. Abdel-Aziz Ali SM, et al. Efficacy of oral agar in management of indirect hyperbilirubinemia in full-term neonates. J Matern Fetal Neonatal Med 2022;35(5):975-980 (PMID 32192396), 2020-03-19. pubmed.ncbi.nlm.nih.gov
  12. Clegg ME, et al. The effect of agar jelly on energy expenditure, appetite, gastric emptying and glycaemic response. Eur J Nutr 2014;53(2):533-9 (PMID 23872837), 2013-07-20. pubmed.ncbi.nlm.nih.gov
  13. Sanaka M, et al. Effects of agar and pectin on gastric emptying and post-prandial glycaemic profiles in healthy human volunteers. Clin Exp Pharmacol Physiol 2007;34(11):1151-5 (PMID 17880369), 2007-11. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in marine and algae: Astaxanthin · Bladderwrack · Chlorella · Dunaliella · Ecklonia cava · Fucoidan · Kelp and seaweed · Sea moss · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.